Tag: bioequivalence
Perception vs Reality: Why Generics Seem Less Effective Than Brand-Name Drugs
Generics contain the exact same active ingredients as brand-name drugs, yet many people believe they're less effective. This gap between science and perception affects adherence, health outcomes, and healthcare costs.
Feb 24 2026
Bioequivalence Explained: FDA Requirements to Prove Generic Drug Equivalence
Bioequivalence is the scientific standard the FDA uses to ensure generic drugs work the same as brand-name versions. It's not about ingredient amounts-it's about how your body absorbs and uses the drug. Here's how it works.
Jan 31 2026
FDA Regulatory Authority: How the Agency Approves Generic Drugs
The FDA ensures generic drugs are safe and effective through the ANDA process, requiring bioequivalence to brand-name drugs without repeating clinical trials. Generics make up 90% of U.S. prescriptions and save billions annually.
Jan 15 2026
International Perspectives on NTI Generics: Regulatory Approaches Compared
NTI generics require strict regulatory oversight due to their narrow safety margin. This article compares how the FDA, EMA, Health Canada, and others regulate these high-risk drugs, highlighting differences in bioequivalence standards, approval timelines, and substitution rules.
Dec 19 2025
Population Pharmacokinetics: How Data Proves Drug Equivalence Across Patient Groups
Population pharmacokinetics uses real-world patient data to prove drug equivalence across diverse groups - not just healthy volunteers. Learn how it's changing generic drug approval and personalized dosing.
Nov 25 2025
